Some noteworthy, newly published congressional hearing volumes on intelligence policy and related topics include the following (mostly pdf).
“Attorney General Guidelines for FBI Criminal Investigations, National Security Investigations, and the Collection of Foreign Intelligence,” Senate Intelligence Committee, September 23, 2008.
“Nomination of Michael Leiter to be Director, National Counterterrorism Center,” Senate Intelligence Committee, May 6, 2008.
“U.S. Interrogation Policy and Executive Order 13440,” Senate Intelligence Committee, September 25, 2007.
“Fixing the Homeland Security Information Network: Finding the Way Forward for Better Information Sharing,” House Homeland Security Committee, May 10, 2007.
“Budget Request on Unmanned Aerial Vehicles (UAV) and Intelligence, Surveillance, and Reconnaissance (ISR) Capabilities,” House Armed Services Committee, April 19, 2007.
Too often, affected patients, clinicians, and regulators cannot see how the system works, why a decision was made, or whether meaningful human oversight occurred.
Existing tools from other domains, such as existing robust public engagement processes in drug development, when applied to AI deployment can help strengthen public trust in these systems and enhance perceptions of their legitimacy and the decisions they produce.
With thoughtful policy action, it is still possible to build systems that are fair, transparent, and accountable, and to earn the public trust that will ultimately determine AI’s future. We hope policymakers are ready to act.
Procurement is not merely an administrative function—it is how AI enters government and the first line of defense for responsible AI in the public sector.